Current and historical daily PE Ratio for PCRX (
Pacira BioSciences Inc
) from 2011 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Pacira BioSciences stock (PCRX) PE ratio as of Apr 27 2024 is 31.72.
More Details
Pacira BioSciences Inc (PCRX) PE Ratio (TTM) Chart
Pacira BioSciences Inc (PCRX) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1217
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Pacira BioSciences PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-27 | 31.7 | 2024-02-23 | 36.2 |
| 2024-04-26 | 31.7 | 2024-02-22 | 36.1 |
| 2024-04-25 | 30.7 | 2024-02-21 | 35.8 |
| 2024-04-24 | 31.2 | 2024-02-20 | 36.0 |
| 2024-04-23 | 32.3 | 2024-02-16 | 35.0 |
| 2024-04-22 | 31.4 | 2024-02-15 | 35.7 |
| 2024-04-19 | 31.6 | 2024-02-14 | 35.2 |
| 2024-04-18 | 31.4 | 2024-02-13 | 35.2 |
| 2024-04-17 | 32.3 | 2024-02-12 | 36.2 |
| 2024-04-16 | 32.4 | 2024-02-09 | 34.7 |
| 2024-04-15 | 32.0 | 2024-02-08 | 33.4 |
| 2024-04-12 | 32.3 | 2024-02-07 | 34.3 |
| 2024-04-11 | 33.0 | 2024-02-06 | 37.1 |
| 2024-04-10 | 33.5 | 2024-02-05 | 37.5 |
| 2024-04-09 | 34.4 | 2024-02-02 | 36.5 |
| 2024-04-08 | 34.3 | 2024-02-01 | 38.3 |
| 2024-04-05 | 33.9 | 2024-01-31 | 39.3 |
| 2024-04-04 | 34.2 | 2024-01-30 | 39.8 |
| 2024-04-03 | 35.0 | 2024-01-29 | 39.1 |
| 2024-04-02 | 34.4 | 2024-01-26 | 38.6 |
| 2024-04-01 | 35.1 | 2024-01-25 | 39.0 |
| 2024-03-28 | 35.2 | 2024-01-24 | 38.8 |
| 2024-03-27 | 35.0 | 2024-01-23 | 39.0 |
| 2024-03-26 | 34.4 | 2024-01-22 | 38.9 |
| 2024-03-25 | 35.2 | 2024-01-19 | 38.4 |
| 2024-03-22 | 34.5 | 2024-01-18 | 38.2 |
| 2024-03-21 | 35.3 | 2024-01-17 | 38.1 |
| 2024-03-20 | 36.2 | 2024-01-16 | 39.0 |
| 2024-03-19 | 35.5 | 2024-01-12 | 38.8 |
| 2024-03-18 | 35.3 | 2024-01-11 | 39.3 |
| 2024-03-15 | 35.4 | 2024-01-10 | 40.0 |
| 2024-03-14 | 35.3 | 2024-01-09 | 41.8 |
| 2024-03-13 | 36.5 | 2024-01-08 | 42.8 |
| 2024-03-12 | 36.8 | 2024-01-05 | 41.3 |
| 2024-03-11 | 37.4 | 2024-01-04 | 39.1 |
| 2024-03-08 | 37.8 | 2024-01-03 | 38.6 |
| 2024-03-07 | 36.9 | 2024-01-02 | 38.5 |
| 2024-03-06 | 36.3 | 2023-12-29 | 40.6 |
| 2024-03-05 | 35.5 | 2023-12-28 | 40.5 |
| 2024-03-04 | 35.2 | 2023-12-27 | 381.2 |
| 2024-03-01 | 34.8 | 2023-12-26 | 373.6 |
| 2024-02-29 | 35.8 | 2023-12-22 | 367.2 |
| 2024-02-28 | 36.0 | 2023-12-21 | 366.3 |
| 2024-02-27 | 36.0 | 2023-12-20 | 357.9 |
| 2024-02-26 | 35.8 | 2023-12-19 | 349.7 |
Pacira BioSciences Inc (PCRX) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Pacira BioSciences Inc
NAICS : 325412
SIC : 2834
ISIN : US6951271005
Description
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers